The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of trilaciclib prior to chemotherapy ± atezolizumab on T-cell activation in patients with newly diagnosed extensive-stage small cell lung cancer.
 
Aaron D. Stevens
Employment - G1 Therapeutics
 
Davey B. Daniel
Research Funding - Abbvie (Inst); Amgen (Inst); ARMO BioSciences (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); G1 Therapeutics (Inst); G1 Therapeutics (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Guardant Health (Inst); Immunomedics (Inst); Janssen Research & Development (Inst); Lilly (Inst); Merck (Inst); Merus NV (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
 
Jerome H. Goldschmidt
Employment - Blue Ridge Cancer Care
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol myers squibb
 
Paul A. Fields
Employment - Adaptive Biotechnologies
Stock and Other Ownership Interests - Adaptherapy
 
Barb Banbury
Employment - Adaptive Biotechnologies
Stock and Other Ownership Interests - Adaptive Biotechnologies
 
Steven Wolfe
Employment - G1 Therapeutics; GlaxoSmithKline (I)
Stock and Other Ownership Interests - G1 Therapeutics; GlaxoSmithKline (I)
 
Jarrett Glass
Employment - G1 Therapeutics
Stock and Other Ownership Interests - G1 Therapeutics
 
Janet K. Horton
Employment - G1 Therapeutics
Stock and Other Ownership Interests - G1 Therapeutics
 
Jessica Sorrentino
Employment - G1 Therapeutics
Stock and Other Ownership Interests - G1 Therapeutics